Top

Published in:

Open Access 26-03-2024 | Sacrocolpopexy | Original Article

Long-Term Mesh Exposure 5 Years Following Minimally Invasive Total Hysterectomy and Sacrocolpopexy

Authors: C. Emi Bretschneider, Erinn R. Myers, Elizabeth J. Geller, Kimberly S. Kenton, Barbara R. Henley, Catherine A. Matthews

Published in: International Urogynecology Journal | Issue 4/2024

Abstract

Introduction and Hypothesis

The objective was to assess long-term mesh complications following total hysterectomy and sacrocolpopexy.

Methods

In this second extension study, women from a multicenter randomized trial were followed for more than 36 months after surgery. Owing to COVID-19, participants were assessed through either in-person visits or telephone questionnaires. The primary outcome was the incidence of permanent suture or mesh exposure. Secondary outcomes included surgical success and late adverse outcomes.

Results

Out of the 200 initially enrolled participants, 82 women took part in this second extension study. Among them, 46 were in the permanent suture group, and 36 in the delayed absorbable group. The mean follow-up duration was 5.3 years, with the cumulative mesh or suture exposure of 9.9%, involving 18 cases, of which 4 were incident cases. Surgical success after more than 5 years stood at 95%, with few experiencing bothersome bulge symptoms or requiring retreatment. No serious adverse events occurred, including mesh erosion into the bladder or bowel. The most common adverse events were vaginal pain, bleeding, dyspareunia, and stress urinary incontinence, with no significant differences between suture types.

Conclusion

The study found that mesh exposure risk gradually increased over time, reaching nearly 10% after more than 5 years post-surgery, regardless of suture type. However, surgical success remained high, and no delayed serious adverse events were reported.

Deprest JA, Cartwright R, Dietz HP, et al. International Urogynecological Consultation (IUC): pathophysiology of pelvic organ prolapse (POP). Int Urogynecol J. 2022;33(7):1699–710. https://doi.org/10.1007/s00192-022-05081-0.CrossRefPubMed

Larouche M, Belzile E, Geoffrion R. Surgical management of symptomatic apical pelvic organ prolapse: a systematic review and meta-analysis. Obstet Gynecol. 2021;137(6):1061–73. https://doi.org/10.1097/AOG.0000000000004393. Erratum in: Obstet Gynecol. 2023;142(2):431.CrossRefPubMed

Fritel X, de Tayrac R, de Keizer J, et al. Serious complications and recurrences after pelvic organ prolapse surgery for 2309 women in the VIGI-MESH registry. BJOG. 2022;129(4):656–63. https://doi.org/10.1111/1471-0528.16892.CrossRefPubMed

Matthews CA, Geller EJ, Henley BR, et al. Permanent compared with absorbable suture for vaginal mesh fixation during total hysterectomy and sacrocolpopexy: a randomized controlled trial. Obstet Gynecol. 2020;136(2):355–64. https://doi.org/10.1097/AOG.0000000000003884.CrossRefPubMed

Matthews CA, Myers EM, Henley BR, et al. Long-term mesh exposure after minimally invasive total hysterectomy and sacrocolpopexy. Int Urogynecol J. 2023;34(1):291–6. https://doi.org/10.1007/s00192-022-05388-y.CrossRefPubMed

Haylen BT, Freeman RM, Swift SE, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint terminology and classification of the complications related directly to the insertion of prostheses (meshes, implants, tapes) and grafts in female pelvic floor surgery. Neurourol Urodyn. 2011;30(1):2–12. https://doi.org/10.1002/nau.21036.CrossRefPubMed

Barber MD, Walters MD, Bump RC. Short forms of two condition-specific quality-of-life questionnaires for women with pelvic floor disorders (PFDI-20 and PFIQ-7). Am J Obstet Gynecol. 2005;193(1):103–13. https://doi.org/10.1016/j.ajog.2004.12.025.CrossRefPubMed

Srikrishna S, Robinson D, Cardozo L. Validation of the Patient Global Impression of Improvement (PGI-I) for urogenital prolapse. Int Urogynecol J. 2010;21(5):523–8. https://doi.org/10.1007/s00192-009-1069-5.CrossRefPubMed

Bump RC, Mattiasson A, Bø K, et al. The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. Am J Obstet Gynecol. 1996;175(1):10–7. https://doi.org/10.1016/s0002-9378(96)70243-0.CrossRefPubMed

10.

Brubaker L, Cundiff GW, Fine P, et al. Abdominal sacrocolpopexy with Burch colposuspension to reduce urinary stress incontinence. N Engl J Med. 2006;354(15):1557–66. https://doi.org/10.1056/NEJMoa054208. Erratum in: N Engl J Med. 2016;374(23):2297–8.CrossRefPubMed

11.

Nygaard I, Brubaker L, Zyczynski HM, et al. Long-term outcomes following abdominal sacrocolpopexy for pelvic organ prolapse. JAMA. 2013;309(19):2016–24. https://doi.org/10.1001/jama.2013.4919. Erratum in: JAMA. 2013;310(10):1076.CrossRefPubMedPubMedCentral

12.

Tan-Kim J, Menefee SA, Luber KM, Nager CW, Lukacz ES. Prevalence and risk factors for mesh erosion after laparoscopic-assisted sacrocolpopexy. Int Urogynecol J. 2011;22(2):205–12. https://doi.org/10.1007/s00192-010-1265-3.CrossRefPubMed

13.

Askew AL, Visco AG, Weidner AC, Truong T, Siddiqui NY, Bradley MS. Does mesh weight affect time to failure after robotic-assisted laparoscopic sacrocolpopexy. Female Pelvic Med Reconstr Surg. 2020;26(9):536–40. https://doi.org/10.1097/SPV.0000000000000632.CrossRefPubMed

14.

Das D, Carroll A, Mueller M, et al. Mesh complications after total vs supracervical laparoscopic hysterectomy at time of minimally invasive sacrocolpopexy. Int Urogynecol J. 2022;33(9):2507–14. https://doi.org/10.1007/s00192-022-05251-0.CrossRefPubMed

15.

Giugale LE, Hansbarger MM, Askew AL, Visco AG, Shepherd JP, Bradley MS. Assessing pelvic organ prolapse recurrence after minimally invasive sacrocolpopexy: does mesh weight matter? Int Urogynecol J. 2021;32(8):2195–201. https://doi.org/10.1007/s00192-021-04681-6.CrossRefPubMed

16.

Culligan PJ, Lewis C, Priestley J, Mushonga N. Long-term outcomes of robotic-assisted laparoscopic sacrocolpopexy using lightweight Y-mesh. Female Pelvic Med Reconstr Surg. 2020;26(3):202–6. https://doi.org/10.1097/SPV.0000000000000788.CrossRefPubMed

Title: Long-Term Mesh Exposure 5 Years Following Minimally Invasive Total Hysterectomy and Sacrocolpopexy
Authors: C. Emi Bretschneider
Erinn R. Myers
Elizabeth J. Geller
Kimberly S. Kenton
Barbara R. Henley
Catherine A. Matthews
Publication date: 26-03-2024
Publisher: Springer International Publishing
Keywords: Sacrocolpopexy
Hysterectomy
Published in: International Urogynecology Journal / Issue 4/2024
Print ISSN: 0937-3462
Electronic ISSN: 1433-3023
DOI: https://doi.org/10.1007/s00192-024-05769-5

At a glance: The STEP trials

Springer Medicine

Long-Term Mesh Exposure 5 Years Following Minimally Invasive Total Hysterectomy and Sacrocolpopexy

Abstract

Introduction and Hypothesis

Methods

Results

Conclusion

At a glance: The STEP trials

Springer Medicine

Abstract

Introduction and Hypothesis

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 4/2024

Cross-Cultural Adaptation and Validation of the ICIQ-BD for Brazilian Women With Lower Urinary Tract Symptoms

Online Group-based Pelvic Floor Muscle Training for Urinary Incontinence in Older Women: a Pilot Study

Perioperative Morbidity Associated with Same-day Discharge in Elderly Patients

The use of animal models in preclinical investigations for the development of a surgical mesh for pelvic organ prolapse

Robotic-assisted intravesical mesh excision following retropubic midurethral sling

Effect of Vaginal Microecological Alterations on Female Pelvic Organ Prolapse